- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Biohaven Pharmaceutical Holding Co is a biotechnology business based in the US. Biohaven Pharmaceutical Holding Co shares (BHVN) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $36.26 – a decrease of 5.74% over the previous week. Biohaven Pharmaceutical Holding Co employs 239 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Biohaven Pharmaceutical Holding Co stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Biohaven Pharmaceutical Holding Co stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BHVN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Biohaven Pharmaceutical Holding Co stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Biohaven Pharmaceutical Holding Co stock price (NYSE: BHVN)
Use our graph to track the performance of BHVN stocks over time.Biohaven Pharmaceutical Holding Co shares at a glance
Information last updated 2024-12-19.
| Latest market close | $36.26 |
|---|---|
| 52-week range | $26.80 - $62.21 |
| 50-day moving average | $48.33 |
| 200-day moving average | $43.35 |
| Wall St. target price | $65.29 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-9.37 |
Is it a good time to buy Biohaven Pharmaceutical Holding Co stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Biohaven Pharmaceutical Holding Co price performance over time
Historical closes compared with the close of $35.34 from 2024-12-19
| 1 week (2024-12-13) | -8.14% |
|---|---|
| 1 month (2024-11-22) | -22.48% |
| 3 months (2024-09-20) | -12.50% |
| 6 months (2024-06-21) | 5.30% |
| 1 year (2023-12-21) | -7.05% |
|---|---|
| 2 years (2022-12-21) | 161.20% |
| 3 years (2021-12-18) | N/A |
| 5 years (2019-12-18) | N/A |
Biohaven Pharmaceutical Holding Co financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -118.79% |
| Return on equity TTM | -265.45% |
| Profit margin | 0% |
| Book value | $3.33 |
| Market Capitalization | $3.6 billion |
TTM: trailing 12 months
Biohaven Pharmaceutical Holding Co share dividends
We're not expecting Biohaven Pharmaceutical Holding Co to pay a dividend over the next 12 months.
Biohaven Pharmaceutical Holding Co share price volatility
Over the last 12 months, Biohaven Pharmaceutical Holding Co's shares have ranged in value from as little as $26.8 up to $62.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Biohaven Pharmaceutical Holding Co's is 4.12. This would suggest that Biohaven Pharmaceutical Holding Co's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Biohaven Pharmaceutical Holding Co overview
Biohaven Ltd. , together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide. The company's pipeline products include Troriluzole, which is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500 that blocks glutamate signaling mediated by post-synaptic NMDA receptors; Taldefgrobep Alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 2/3 clinical trials for the treatment of focal and generalized epilepsy, bipolar disorder, and major depressive disorder; BHV-2100 that is in Phase 1 clinical trials for the treatment of migraines and neuropathic pain; and BHV-8000, a product candidate in Phase 1 clinical trials for the treatment of early Alzheimer's and Parkinson's disease, sclerosis, and amyloid-related imaging abnormalities. It also offers BHV-1300, a product candidate in Phase 1 clinical trials to treat rheumatoid arthritis; BHV-1310 for the treatment of generalized myasthenia gravis and acute exacerbations or flares; BHV-1400 to treat IgA Nephropathy; and BHV-1600 for the treatment of dilated cardiomyopathy. In addition, the company develops BHV-1100, a product candidate in Phase 1a/1b clinical trials for multiple myeloma patients; BHV-1510, a preclinical product that targets carcinomas; and BHV-1500 for Hodgkin's lymphoma. It has license, development, and commercialization agreements with Yale University, AstraZeneca, University of Connecticut, Artizan Biosciences Inc. , Reliant Glycosciences LLC, Katholieke Universiteit Leuven, BMS, and Highlightll Pharmaceutical Co.
Frequently asked questions
What percentage of Biohaven Pharmaceutical Holding Co is owned by insiders or institutions?Currently 11.158% of Biohaven Pharmaceutical Holding Co shares are held by insiders and 87.169% by institutions. How many people work for Biohaven Pharmaceutical Holding Co?
Latest data suggests 239 work at Biohaven Pharmaceutical Holding Co. When does the fiscal year end for Biohaven Pharmaceutical Holding Co?
Biohaven Pharmaceutical Holding Co's fiscal year ends in December. Where is Biohaven Pharmaceutical Holding Co based?
Biohaven Pharmaceutical Holding Co's address is: 215 Church Street, New Haven, CT, United States, 06510 What is Biohaven Pharmaceutical Holding Co's ISIN number?
Biohaven Pharmaceutical Holding Co's international securities identification number is: VGG111961055
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question